Literature DB >> 30251551

Pharmacokinetics and drug metabolism of antibiotics in the elderly.

Federico Pea1,2.   

Abstract

INTRODUCTION: The number of elderly people is increasing worldwide. The elderly may be at increased risk of bacterial infections compared with younger adults. Dosing adaptation of antibiotics in this population may be difficult due to changes in body composition, decline of renal function and/or drug-drug interactions. Lack of dose adaptation may cause unintentional overdosing with the risk of severe adverse effects. Areas covered: This review is based on a PubMed search of the literature published in English language and concerns pharmacokinetic (PK) studies of antibiotics in the elderly performed between 1971 and 2017. Expert opinion: Appropriateness of drug prescription in the elderly is a major commitment of the health care systems worldwide. This should push more and more clinicians to adjust the dosage of renally cleared antibiotics in relation to renal function estimates. The situation may become even more complex in frail elderly patients who are receiving polypharmacy due to drug-drug interactions. Development of new antibiotics should include within clinical trials adequate representation of patients aged ≥75 years to determine age-based dosing. Population PK could be helpful in increasing the knowledge of clinical factors influencing the need for dosing adaptation of the currently available antibiotics in the elderly.

Entities:  

Keywords:  Elderly; antibiotics; clearance; drug–drug interaction; polypharmacy; renal function

Mesh:

Substances:

Year:  2018        PMID: 30251551     DOI: 10.1080/17425255.2018.1528226

Source DB:  PubMed          Journal:  Expert Opin Drug Metab Toxicol        ISSN: 1742-5255            Impact factor:   4.481


  7 in total

1.  Amoxicillin-induced crystal nephropathy: A nationwide French pharmacovigilance databases study.

Authors:  Laure Thomas; Christine Le Beller; Thierry Trenque; Joëlle Michot; Marie Zenut; Emmanuel Letavernier; Nicolas Mongardon; Dominique Vodovar
Journal:  Br J Clin Pharmacol       Date:  2020-06-17       Impact factor: 4.335

Review 2.  Pharmacological Interactions in the Elderly.

Authors:  Emilia Błeszyńska; Łukasz Wierucki; Tomasz Zdrojewski; Marcin Renke
Journal:  Medicina (Kaunas)       Date:  2020-06-28       Impact factor: 2.430

3.  Therapeutic drug monitoring of amikacin: quantification in plasma by liquid chromatography-tandem mass spectrometry and work experience of clinical pharmacists.

Authors:  Lijie Xu; Xuefang Cheng; Guanhua Zhu; Juanni Hu; Qin Li; Guorong Fan
Journal:  Eur J Hosp Pharm       Date:  2021-11-17

4.  Clinical study on the safety and efficacy of high-dose tigecycline in the elderly patients with multidrug-resistant bacterial infections: A retrospective analysis.

Authors:  Guolian Xia; Ronglin Jiang
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.889

5.  Development of a physiologically based pharmacokinetic (PBPK) population model for Chinese elderly subjects.

Authors:  Cheng Cui; Jie En Valerie Sia; Siqi Tu; Xiaobei Li; Zhongqi Dong; Zhiheng Yu; Xueting Yao; Oliver Hatley; Haiyan Li; Dongyang Liu
Journal:  Br J Clin Pharmacol       Date:  2021-05-18       Impact factor: 4.335

Review 6.  Drug-Drug Interactions in Vestibular Diseases, Clinical Problems, and Medico-Legal Implications.

Authors:  Giulio Di Mizio; Gianmarco Marcianò; Caterina Palleria; Lucia Muraca; Vincenzo Rania; Roberta Roberti; Giuseppe Spaziano; Amalia Piscopo; Valeria Ciconte; Nunzio Di Nunno; Massimiliano Esposito; Pasquale Viola; Davide Pisani; Giovambattista De Sarro; Milena Raffi; Alessandro Piras; Giuseppe Chiarella; Luca Gallelli
Journal:  Int J Environ Res Public Health       Date:  2021-12-08       Impact factor: 3.390

Review 7.  Antibiotics and ECMO in the Adult Population-Persistent Challenges and Practical Guides.

Authors:  Francisco Gomez; Jesyree Veita; Krzysztof Laudanski
Journal:  Antibiotics (Basel)       Date:  2022-03-04
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.